MicroPort Endovascular MedTech Ltd (688016) — Cash Flow Reinvestment Rate
MicroPort Endovascular MedTech Ltd (688016) has a Cash Flow Reinvestment Rate of 1.84x as of September 2025, reinvesting CN¥86.03 Million (capex CN¥86.03 Million ) from operating cash flow of CN¥46.79 Million. Explore 688016 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
MicroPort Endovascular MedTech Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for MicroPort Endovascular MedTech Ltd across 10 annual periods. Also explore 688016 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year capital reinvestment analysis for MicroPort Endovascular MedTech Ltd. For live market cap and broader valuation context, see how much is MicroPort Endovascular MedTech Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | CN¥387.06 Million | CN¥573.06 Million | CN¥303.03 Million | ▼ -9.9% |
| 2024 | 0.75x | CN¥280.12 Million | CN¥373.60 Million | CN¥212.65 Million | ▼ -54.3% |
| 2023 | 1.64x | CN¥937.55 Million | CN¥571.22 Million | CN¥190.26 Million | ▼ -25.3% |
| 2022 | 2.20x | CN¥733.78 Million | CN¥333.76 Million | CN¥293.98 Million | ▲ +302.1% |
| 2021 | 0.55x | CN¥164.15 Million | CN¥300.25 Million | CN¥89.58 Million | ▲ +240.6% |
| 2020 | 0.16x | CN¥34.90 Million | CN¥217.44 Million | CN¥26.22 Million | ▼ -28.8% |
| 2019 | 0.23x | CN¥32.30 Million | CN¥143.20 Million | CN¥21.24 Million | ▼ -51.5% |
| 2018 | 0.47x | CN¥49.70 Million | CN¥106.85 Million | CN¥24.90 Million | ▲ +13.2% |
| 2017 | 0.41x | CN¥28.49 Million | CN¥69.36 Million | CN¥28.23 Million | ▼ -80.6% |
| 2016 | 2.12x | CN¥63.77 Million | CN¥30.13 Million | CN¥31.81 Million | — |